Eri Nagao

Title: Eri Nagao: Innovator in Hepatotoxicity Evaluation

Introduction

Eri Nagao is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biomedical engineering, particularly in the development of human liver-like structures for toxicity evaluation.

Latest Patents

Eri Nagao holds a patent for a groundbreaking invention titled "Human liver-like three-dimensional structure, method for evaluating hepatotoxicity and human liver-like complex." This innovative construct allows for accurate and simple evaluation of human-specific toxicity. The invention features a human liver-like three-dimensional construct comprising a heterospheroid, which aggregates human hepatic cells with other human-derived cells. The unique aspect of this construct is that the other human-derived cells include at least one type selected from human hepatic stellate cells, with a specific ratio to human hepatic cells.

Career Highlights

Eri Nagao is associated with Cyfuse Biomedical K.K., where she continues to advance her research and development efforts. Her work has been instrumental in creating models that can mimic human liver functions, which are crucial for drug testing and toxicity assessments.

Collaborations

Eri collaborates with notable colleagues, including Toshihiko Maekawa and Izumi Ide. Their combined expertise enhances the research and development processes at Cyfuse Biomedical K.K.

Conclusion

Eri Nagao's innovative work in creating a human liver-like three-dimensional construct represents a significant advancement in the field of hepatotoxicity evaluation. Her contributions are paving the way for more accurate and efficient drug testing methodologies.